Latest filing published 16 May 2008 for PROGENICS PHARMACEUTICALS INC, €7,135.
Insider track record
No signal scores available.
Mark F. Dalton: trading record in brief
All filings by Mark F. Dalton on record concern Progenics Pharmaceuticals Inc. In total, 3 filings cover trades dated 14 May 2008.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 16 May 2008 with an option exercise (€7,135) in Progenics Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark F. Dalton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$4.41Common StockSEC:0001266375-08-000022:0
- 2,500 shares@ US$6.66Common StockSEC:0001266375-08-000022:1
- 2,500 shares@ US$5.02Common StockSEC:0001266375-08-000022:2
3 of 3 declarations
